Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive modeling of therapy response in multiple sclerosis using gene expression data.

Sara Mostafavi1, Sergio Baranzini, Jorge Oksernberg

  • 1School of Computing, Queen's University, Kingston, ON, Canada. sara@cs.queensu.ca

Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
|October 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long QT Syndrome Type 5 With Coexisting KCNE1 and RYR2 Variants: A Diagnostic Ambiguity.

Clinical case reports·2026
Same author

A scalable approach to investigating sequence-to-function predictions from personal genomes.

Nature methods·2026
Same author

Reducing robotic upper-limb assessment time while maintaining precision: a time series foundation model approach.

Journal of neuroengineering and rehabilitation·2026
Same author

Effect of Online Mindfulness-Based Stress Reduction on Psychological Distress and Pregnancy Rate in Infertile Women Undergoing In Vitro Fertilization.

Obstetrics and gynecology international·2026
Same author

Shift happens: a fairness-oriented framework for medical classification under hidden bias.

International journal of computer assisted radiology and surgery·2026
Same author

GUIDE-US: grade-informed unpaired distillation of encoder knowledge from histopathology to micro-ultrasound.

International journal of computer assisted radiology and surgery·2026

OSeMA, a novel gene selection framework, accurately predicts interferon-beta (IFNB) therapy response in multiple sclerosis patients. This computational approach enhances prediction accuracy by optimizing gene selection for robust classification models.

Area of Science:

  • Computational biology
  • Genomics
  • Translational medicine

Background:

  • Transcription profiling provides insights into molecular events influencing drug therapy response.
  • Accurate predictive models require precise data, robust gene selection, advanced computational methods, and validation.
  • Gene selection is a bottleneck in computational modeling due to the high dimensionality of gene expression data.

Purpose of the Study:

  • To present OSeMA, a fast, robust, and accurate gene selection-classification framework.
  • To develop highly predictive classification models for interferon-beta (IFNB) therapy response in multiple sclerosis (MS) patients.

Main Methods:

  • Development of the OSeMA (Optimal Set Gene selection and Modeling Approach) framework.
  • Application of OSeMA for gene selection and classification model construction.

Related Experiment Videos

  • Performance assessment on held-out test data and comparison with exhaustive combinatorial methods.

    • Main Results:

    • OSeMA demonstrates high predictive accuracy for IFNB therapy response in MS patients.
    • The framework is computationally efficient and robust in gene selection.
    • Evaluations confirm OSeMA's superior performance compared to exhaustive approaches.

    Conclusions:

    • OSeMA offers a significant advancement in developing predictive models for therapy response.
    • The framework addresses the challenges of gene selection in high-dimensional transcriptomic data.
    • OSeMA facilitates more accurate and reliable predictions for personalized medicine in MS.